Hutchison China Meditech Ltd., of Hong Kong, appointed Paul Rutherford Carter senior independent non-executive director and member of the audit committee, remuneration committee and technical committee. Carter has more than 25 years of experience in the pharmaceutical industry. From 2006 to 2016, he served in various senior executive roles at Gilead Sciences Inc., with the last position as executive vice president, commercial operations. Prior to joining Gilead, he spent 14 years with Glaxosmithkline plc and its group companies, with the last position as a regional head of the international business in Asia.

No Comments